[1] 丁建东,马根山.心力衰竭合并瓣膜性心脏病介入治疗研究现状[J].中国实用内科杂志,2020,40(12):990-995.
[2] SORAJJA P,VEMULAPALLI S,FELDMAN T,et al.Outcomes with transcatheter mitral valve repair in the united states:an STS/ACC TVT registry report[J].J Am Coll Cardiol,2017,70(19):2315-2327.
[3] NKOMO V T,GARDIN J M,SKELTON T N,et al.Burden of valvular heart diseases:a population-based study[J].Lancet,2006,368(9540):1005-1011.
[4] JONES E C,DEVEREUX R B,ROMAN M J,et al.Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study)[J].Am J Cardiol,2001,87(3):298-304.
[5] 潘文志,周达新,葛均波.中国二尖瓣反流患者人群数量的估测[J].中国胸心血管外科临床杂志,2021,28(5):495-498.
[6] 王华,李莹莹,柴坷,等.中国住院心力衰竭患者流行病学及治疗现状[J].中华心血管病杂志,2019,47(11):865-874.
[7] LABROUSSE L,DIJOS M,LEROUX L,et al.Guidance of the MitraClip® procedure by 2D and 3D imaging[J].Arch Cardiovasc Dis,2018,111(6-7):432-440.
[8] SORAJJA P,UKAIGWE A C.Edge-to-edge repair:past challenge,current case selection and future advances[J].Ann Cardiothorac Surg,2021,10(1):43-49.
[9] LANCELLOTTI P,TRIBOUILLOY C,HAGENDORFF A,et al.Recommendations for the echocardiographic assessment of native valvular regurgitation:an executive summary from the European association of cardiovascular imaging[J].Eur Heart J Cardiovasc Imaging,2013,14(7):611-644.
[10] 潘翠珍,潘文志,周达新.二尖瓣反流介入治疗的超声心动图评价中国专家共识[J].中国介入心脏病学杂志,2019,27(1):6-12.
[11] CHEEMA F H,LOYALKA P,RAJAGOPAL K.Defining the role of MitraClip therapy for mitral valve regurgitation[J].Tex Heart Inst J,2020,47(2):130-133.
[12] WALTHER C,FICHTLSCHERER S,HOLUBEC T,et al.New developments in transcatheter therapy of mitral valve disease[J].Thorac Dis,2020(4):1728-1739.
[13] LAVALL D,HAGENDORFF A,SCHIRMER S H,et al.Mitral valve interventions in heart failure[J].ESC Heart Fail,2018,5(4):552-561.
[14] CONDADO J A,ACQUATELLA H,RODRIGUEZ L,et al.Percutaneous edge-to-edge mitral valve repair:2-year follow-up in the first human case[J].Catheter Cardiovasc Interv,2006,67(2):323-325.
[15] WHITLOW P L,FELDMAN T,PEDERSEN W R,et al.Acute and 12-month results with catheter-based mitral valve leaflet repair:the EVEREST Ⅱ(Endovascular Valve Edge-to-Edge Repair)high risk study[J].J Am Coll Cardiol,2012,59(2):130-139.
[16] SORAJJA P,VEMULAPALLI S,FELDMAN T,et al.Outcomes with transcatheter mitral valve repair in the united states:an STS/ACC TVT registry report[J].J Am Coll Cardiol,2017,70(19):2315-2327.
[17] STONE G W,LINDENFELD J,ABRAHAM W T,et al.Transcatheter mitral-valve repair in patients with heart failure[J].N Engl J Med,2018,379(24):2307-2318.
[18] OBADIA J F,MESSIKA-ZEITOUN D,LEURENT G,et al.Percutaneous repair or medical treatment for secondary mitral regurgitation[J].N Engl J Med,2018,379(24):2297-2306.
[19] WONG N,YEO K K.MitraClip in Asia-current adoption and regional data[J].Circ Rep,2019,1(10):397-400.
[20] YEO K K,YAP J,YAMEN E,et al.Percutaneous mitral valve repair with the MitraClip:early results from the MitraClip Asia-Pacific Registry (MARS)[J].EuroIntervention,2014,10(5):620-625.
[21] HAYASHIDA K,YASUDA S,MATSUMOTO T,et al.AVJ-514 trial-baseline characteristics and 30-day outcomes following MitraClip® treatment in a Japanese cohort[J].Circ J,2017,81:1116-1122.
[22] LEE C W,SUNG S H,TSAI Y L,et al.Initial experience with percutaneous edge-to-edge transcatheter mitral valve repair in a tertiary medical center in Taiwan[J].J Chin Med Assoc,2018,81:305-310.
[23] 葛均波,周达新,潘文志,等.经导管二尖瓣修复术治疗重度二尖瓣返流的初步经验[J].中华心血管病杂志,2013,41(2):99-102. |